Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy

被引:8
作者
Dimopoulos, Spyridon [1 ]
Leitritz, Martin Alexander [1 ]
Ziemssen, Focke [1 ]
Voykov, Bogomil [1 ]
Bartz-Schmidt, Karl Ulrich [1 ]
Gelisken, Faik [1 ]
机构
[1] Univ Tubingen, Ctr Ophthalmol, Schleichstr 12, D-72076 Tubingen, Germany
来源
CLINICAL OPHTHALMOLOGY | 2015年 / 9卷
关键词
age-related macular degeneration; bevacizumab; submacular hemorrhage;
D O I
10.2147/OPTH.S87919
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report the visual and morphological outcomes following intravitreal bevacizumab in neovascular age-related macular degeneration (nAMD) with submacular, predominantly hemorrhagic, lesions. Methods: Retrospective study of patients with a follow-up after 1 year. All eyes with submacular hemorrhages larger than 50% of the total lesion size and received only anti-VEGF (vascular endothelial growth factor) monotherapy (intravitreous administration of 1.25 mg bevacizumab, PRN). The primary endpoint was the change in hemorrhage size and time to resolution, in association with the mean best-corrected visual acuity (BCVA). The eyes were grouped based on the size of the hemorrhage: group A (> 1 to <4 disc area [DA]), group B (>4 to <9 DA), and group C (>= 9 DA). Results: Forty-six consecutive eyes were included. The mean area of the hemorrhage was 6 DA at baseline. Eyes with smaller bleeding (group A) had better chances of stabilized or improved vision. Complete resolution of the hemorrhage was seen in 96% of the eyes within 1 year. The mean BCVA increased from 0.81 logarithm of the minimum angle of resolution (logMAR) (95% confidence interval [CI]: 0.70-0.92) (Snellen 20/125) at baseline to 0.75 logMAR (95% CI: 0.62-0.88) (20/125) after 1 year (P=0.11). BCVA improved (one or more ETDRS [Early Treatment of Diabetic Retinopathy Study] lines) in 57% of the eyes (13/23) in group A; 53% (8/15) in group B; and 38% (3/8) in group C. Conclusion: Many of the eyes with hemorrhagic lesions showed stabilization or improvement of the mean BCVA after treatment within 1 year. Anti-VEGF treatment can be considered as a useful treatment option in eyes with hemorrhages secondary to nAMD.
引用
收藏
页码:1537 / 1541
页数:5
相关论文
共 26 条
[1]   Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) [J].
Altaweel, Michael M. ;
Daniel, Ebenezer ;
Martin, Daniel F. ;
Mittra, Robert A. ;
Grunwald, Juan E. ;
Lai, Michael M. ;
Melamud, Alexander ;
Morse, Lawrence S. ;
Huang, Jiayan ;
Ferris, Frederick L., III ;
Fine, Stuart L. ;
Maguire, Maureen G. .
OPHTHALMOLOGY, 2015, 122 (02) :391-+
[2]  
Arias L, 2010, CLIN OPHTHALMOL, V4, P67
[3]   Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration [J].
Avery, RL ;
Fekrat, S ;
Hawkins, BS ;
Bressler, NM .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1996, 16 (03) :183-189
[4]   FACTORS PROGNOSTIC OF VISUAL OUTCOME IN PATIENTS WITH SUBRETINAL HEMORRHAGE [J].
BENNETT, SR ;
FOLK, JC ;
BLODI, CF ;
KLUGMAN, M .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 109 (01) :33-37
[5]  
Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900
[6]   Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findings - SST report no. 13 [J].
Bressler, NM ;
Bressler, SB ;
Childs, AL ;
Haller, JA ;
Hawkins, BS ;
Lewis, H ;
MacCumber, MW ;
Marsh, MJ ;
Redford, M ;
Sternberg, P ;
Thomas, MA ;
Williams, GA .
OPHTHALMOLOGY, 2004, 111 (11) :1993-2006
[7]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[8]   PROSPECTIVE ONE-YEAR STUDY OF RANIBIZUMAB FOR PREDOMINANTLY HEMORRHAGIC CHOROIDAL NEOVASCULAR LESIONS IN AGE-RELATED MACULAR DEGENERATION [J].
Chang, Margaret A. ;
Do, Diana V. ;
Bressler, Susan B. ;
Cassard, Sandra D. ;
Gower, Emily W. ;
Bressler, Neil M. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (08) :1171-1176
[9]   Management of Thick Submacular Hemorrhage With Subretinal Tissue Plasminogen Activator and Pneumatic Displacement for Age-Related Macular Degeneration [J].
Chang, Woohyok ;
Garg, Sunir J. ;
Maturi, Raj ;
Hsu, Jason ;
Sivalingam, Arunan ;
Gupta, Seema A. ;
Regillo, Carl D. ;
Ho, Allen C. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (06) :1250-1257
[10]   INTRAVITREAL RANIBIZUMAB INJECTIONS WITH AND WITHOUT PNEUMATIC DISPLACEMENT FOR TREATING SUBMACULAR HEMORRHAGE SECONDARY TO NEOVASCULAR AGE-RELATED MACULAR DEGENERATION [J].
Cho, Han Joo ;
Koh, Kyoung Min ;
Kim, Jae Hui ;
Kim, Hyoung Seok ;
Han, Jung Il ;
Lew, Young Ju ;
Lee, Tae Gon ;
Kim, Jong Woo .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (02) :205-212